Staff
Personnel at the end of the year
Staff turnover in EUR
Turnover Label
The stock: denominated in EURO
Shares outstanding (in millions)
Dividend per share
Undiluted earnings per share
Boss v Mio. EURO nach IAS / IFRS
Turnover
Operating income (EBIT)
Profit before tax (EBT)
Annual net profit/ loss
Balance sheet in millions of Euro IAS / IFRS
Assets
Total current assets
Total fixed assets
Total assets
Liabilities
Total short-term liabilities
Total long-term liabilities
Total provisions
Equity capital
Total liabilities
Management:
David Veitch
Gerrit Hauck
Laurenz Kellenberger
Marc Engelhardt
Adesh Kaul
Damian Heller
Ph.D. Mark Jones
Ph.D. Peter Bielmeier
Raimond Grewenig-Scheurich
Ursula Eberhardt
Board:
Alf Gunnar Martin Nicklasson
Carole Sable
Nicole Onetto
Thomas Werner
Leonard Kruimer
Stephan Schindler
Shareholding in %:
ACATIS Investment Kapitalverwaltungsgesellschaft mbH 2.61
American Century Investment Management, Inc. 2.37
Basilea Pharmaceutica AG 7.57
Black Creek Investment Management, Inc. 2.93
BlackRock Fund Advisors 2.62
DWS Investments (UK) Ltd. 0.96
Dimensional Fund Advisors LP 1.17
UBS Asset Management Switzerland AG 4.95
Vanguard Capital Management LLC 2.89
Zürcher Kantonalbank (Investment Management) 2.42
Freefloat 69.51
Address: Hegenheimermattweg 167b, 4123 Allschwil
T: +41-61-606-11-11
F: +
I: http://www.basilea.com
E: info@basilea.com